Publications by authors named "Robert Somer"

Claim this Profile
S
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels.
Benjamin Pradere, Maarten Schuit, Félix Guerrero-Ramos, Shahrokh F Shariat, Hiroshi Kitamura, Robert Somer

Curr Opin Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship.
Issam I Raad, Ray Hachem, Nigo Masayuki, Tarcila Datoguia, Hiba Dagher, Robert Somer

Elife· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship.
Issam Raad, Ray Hachem, Nigo Masayuki, Tarcila Datoguia, Hiba Dagher, Robert Somer

medRxiv· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting Prostate Cancer Using Pattern Recognition Neural Networks With Flow Cytometry-Based Immunophenotyping in At-Risk Men.
George A Dominguez, Alexander T Polo, John Roop, Anthony J Campisi, Robert A Somer

Biomark Insights· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing in 305 Consecutive Patients: Clinical Outcomes and Management Changes.
William Davis, Gabriel Makar, Pallav Mehta, Gord G Zhu, Robert Somer

J Oncol Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel K224T missense mutation in a patient with MEN1 syndrome.
Joanna Tolin, Lisa Reid, Robert A Somer, Farah Hena Morgan

Hormones (Athens)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer.
Chelsea K Osterman, Dilip S Babu, Daniel M Geynisman, Bianca Lewis, Robert A Somer

Oncologist· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
Luc Y Dirix, Istvan Takacs, Guy Jerusalem, Petros Nikolinakos, Hendrik-Tobias Arkenau, Robert Somer

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature.
Jeffrey J Levine, Robert A Somer, Hitomi Hosoya, Christian Squillante

Clin Genitourin Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
Ravi G Gupta, Robert A Somer

Mol Cancer Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Renal Cell Carcinoma to Jejunum: An Unusual Case Presentation.
Igor Medic, Miriam L Enriquez, Robert A Somer

Urol Case Rep· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Metastasis Responsive to Pazopanib in Renal Cell Carcinoma: A Case Report and Review of the Literature.
Megan E Gooch, Kamyar Nader, Gregory J Kubicek, Robert A Somer

Clin Genitourin Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of Primary Care Among Breast Cancer Survivors: The Effects of Weight Status.
Allison Christian, Shawna V Hudson, Suzanne M Miller, Alicja Bator, Pamela A Ohman-Strickland, Robert A Somer

Health Serv Res Manag Epidemiol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label safety study of lapatinib plus trastuzumab plus paclitaxel in first-line HER2-positive metastatic breast cancer.
Francisco J Esteva, Sandra X Franco, Maura K Hagan, Abenaa M Brewster, Robert A Somer

Oncologist· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy.
Elyce Cardonick, Dzhamala Gilmandyar, Robert A Somer

Obstet Gynecol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer.
James P Stevenson, Corey J Langer, Robert A Somer, Tracey L Evans, Kumar Rajagopalan

Cancer· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic renal cell carcinoma to the phalanx.
Douglas F Beach, Robert Somer

Urology· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A wealth of new options: a case presentation of the management of castration-recurrent prostate cancer.
Douglas F Beach, Robert A Somer, Jean Hoffman-Censits, Jianqing Lin, Yu-Ning Wong

Semin Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approach to Gorlin syndrome: a patient treated with oral capecitabine.
Douglas F Beach, Robert Somer

J Clin Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance therapy for metastatic non-small-cell lung cancer - the role of pemetrexed.
Youval Katz, Robert A Somer

Lung Cancer (Auckl)· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599.
Robert A Somer, Eric Sherman, Corey J Langer

Clin Lung Cancer· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinoma.
Corey J Langer, Robert Somer, Samuel Litwin, Steven Feigenberg, Benjamin Movsas

J Thorac Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to temozolomide in second-line treatment of recurrent nonsmall cell lung carcinoma: case report.
Robert A Somer, Corey J Langer

Cancer Invest· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific minibodies targeting HER2/neu and CD16 exhibit improved tumor lysis when placed in a divalent tumor antigen binding format.
Lillian S Shahied, Yong Tang, R Katherine Alpaugh, Robert Somer, Dana Greenspon

J Biol Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patients.
Christian S Adonizio, James S Babb, Christine Maiale, Chao Huang, Judy Donahue, Robert Somer

Clin Lung Cancer· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis